Cost effectiveness of ulcerative colitis surveillance in the setting of 5-aminosalicylates (Q37393339)

20 August 2017

Cost effectiveness of ulcerative colitis surveillance in the setting of 5-aminosalicylates (English)

1 reference

cost-effectiveness analysis

20 August 2017

1 reference

1 reference

Joel H Rubenstein

1 reference

20 August 2017

Akbar K Waljee

1 reference

20 August 2017

Joanne M Jeter

1 reference

20 August 2017

Fernando S Velayos

1 reference

20 August 2017

Uri Ladabaum

1 reference

20 August 2017

Peter D R Higgins

1 reference

20 August 2017

language of work or name

English

0 references

publication date

2 June 2009

1 reference

The American Journal of Gastroenterology

20 August 2017

1 reference

20 August 2017

104

1 reference

20 August 2017

1 reference

20 August 2017

2222-2232

1 reference

Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

5-aminosalicylic acid in combination with nimesulide inhibits proliferation of colon carcinoma cells in vitro

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

5-ASA affects cell cycle progression in colorectal cells by reversibly activating a replication checkpoint

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Development and validation of MIX: comprehensive free software for meta-analysis of causal research data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Statins and the risk of colorectal cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

The price tag on progress--chemotherapy for colorectal cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Diagnosis and management of dysplasia in patients with inflammatory bowel diseases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

What is the price of life and why doesn't it increase at the rate of inflation?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

A decision analysis of surveillance for colorectal cancer in ulcerative colitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

5-aminosalicylic acid enhances anchorage-independent colorectal cancer cell death.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Risk factors for morbidity and mortality after colectomy for colon cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Utility valuations for outcome states of colorectal cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Cost-effectiveness of 5-aminosalicylic acid therapy for maintenance of remission in ulcerative colitis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Colorectal cancer prevention in ulcerative colitis: a case-control study.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Risk factors of colorectal cancer in inflammatory bowel disease

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Optimal timing of colonoscopy to screen for cancer in ulcerative colitis

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Early outcome after emergency and elective surgery for ulcerative colitis

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Inflammatory bowel disease: medical cost algorithms

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Medicare cost in matched hospice and non-hospice cohorts.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Incidence and therapeutic outcome of pouchitis for ulcerative colitis in Japanese patients

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

A cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal pouch-anal anastomosis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764368

Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study

2 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FAJG.2009.264

Mesalazine changes apoptosis and proliferation in normal mucosa of patients with sporadic polyps of the large bowel

21 January 2018

1 reference

12 December 2020

5-aminosalicyclic acid and olsalazine inhibit tumor growth in a rodent model of colorectal cancer

1 reference

12 December 2020

A prospective evaluation of health-related quality of life after ileal pouch anal anastomosis for ulcerative colitis

1 reference

12 December 2020

Complications of colonoscopy

1 reference

12 December 2020

Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County

1 reference

12 December 2020

Mortality in inflammatory bowel disease: a population-based cohort study

1 reference

12 December 2020

Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis

1 reference

12 December 2020

Course of ulcerative colitis: analysis of changes in disease activity over years

1 reference

12 December 2020

Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis

1 reference

12 December 2020

Multicentre study of surgical complications of colonoscopy

1 reference

12 December 2020

The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis

1 reference

12 December 2020

Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis

1 reference

12 December 2020

The role of colonoscopy in the management of patients with inflammatory bowel disease. American Society for Gastrointestinal Endoscopy

1 reference

12 December 2020

Mesalazine downregulates c-Myc in human colon cancer cells. A key to its chemopreventive action?

1 reference

12 December 2020

Mesalazine-induced apoptosis of colorectal cancer: on the verge of a new chemopreventive era?

1 reference

12 December 2020

Identifiers

DOI

10.1038/AJG.2009.264

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

19491824

1 reference